• Superbugs & Superdrugs USA

    Renaissance Woodbridge Hotel 515 US-1, Iselin, NJ, United States

    SMi Group will host this year's Superbugs and Superdrugs USA on November 13-14, 2017 in Iselin, New Jersey. Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect

  • Superbugs & Superdrugs 2018

    Copthorne Tara Hotel Kensington, London, United Kingdom

    SMi Group’s 20th Annual Superbugs & Superdrugs conference will take place 19-20 March, 2018 in London, UK. This leading event provides a focal point to push industry collaboration through updates on clinical advancements and investment opportunities. The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug

  • Superbugs & Superdrugs USA

    Renaissance Woodbridge Hotel 515 US-1, Iselin, NJ, United States

    The 2018 Superbugs & Superdrugs USA conference will be held 12-13 November 2018 in Iselin, New Jersey. This 3rd annual Superbugs & Superdrugs USA conference will help participants to learn about pathogen focused drug development; discover the best methods to overcome bacterial resistance through novel modes of action; discuss the state of developments within the

  • U.S. Antibiotic Awareness Week (USAAW)

    Nationwide - U.S. , United States

    U.S. Antibiotic Awareness Week is November 12-18, 2018. Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die as a direct result of these infections. Many more will die from complications by an antibiotic-resistant infection. Join the Centers for Disease

  • Mass Drug Administration and Antimicrobial Resistance

    John Snow Lecture Theatre - LSHTM Keppel Street, London, United Kingdom

    The London School of Hygiene & Tropical Medicine Antimicrobial Resistance Center, together with the MARCH and Malaria Centres will jointly host the Mass Drug Administration and Antimicrobial Resistance Symposium on 20 February 2019 in London, UK and by live stream. Mass Drug Administration is an intervention proposed to reduce morbidity and mortality of entire populations. This symposium

  • Superbugs & Superdrugs 2019

    Holiday Inn Kensington Forum 97 Cromwell Rd, London, United Kingdom

    SMi Group’s Annual Superbugs & Superdrugs conference will take place 18-19 March, 2019 in London, UK. This year’s event will gather leaders from pharmaceutical companies, academia and the wider scientific community together with regulatory agencies and public-private partnerships, to discuss the growing threat of antibiotic resistance. Highlighted session topics and focus areas include: Development of

  • Diagnostic Microbiology and Infectious Diseases Summit

    Dubai, UAE Dubai, UAE

    The Diagnostic Microbiology and Infectious Diseases Summit will be held 9-10 September 2019 in Dubai, UAE. This event provides a pivotal platform to explore outstanding strategies in Diagnostic Microbiology and Infectious Diseases. Highlighted topic sessions include: Resistance and mechanisms of action of antifungalsImmunology of infectious diseasesClinical microbiologyEpidemiology of infectious diseases and public health concernsMedical and

  • BARDA Vaccines Against AMR Threats Virtual Workshop

    Virtual Event

    Join the Biomedical Advanced Research and Development Authority (BARDA) at the Vaccines against AMR Threats virtual workshop on March 12, 2021 from 11:00am - 1:00pm Eastern. Multi-drug resistant (MDR) organisms are a threat to national security and public health. As rates of antimicrobial resistance (AMR) in pathogens continue to increase new therapeutics and vaccines are essential

  • Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States

    Virtual Event

    The National Academies will convene a meeting Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States on March 16-19, 2021 via virtual format. During these meetings, expert speakers will discuss GARP’s work developing treatments for drug-resistant infections and CMS reimbursement for new antibiotics. Speakers will also present on the challenges